SOURCE: Trxade Group, Inc.

Trxade Group, Inc.

October 01, 2015 09:00 ET

Fundamental Research Corp Announces It Initiated Coverage of Trxade Group, Inc.

TAMPA, FL--(Marketwired - Oct 1, 2015) - Trxade Group, Inc., (OTCQB: TRXD) is a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally (wholesalers). Currently, the company's market platform is used mainly by around 4,300 retail pharmacies to purchase drugs from 24 wholesalers (supplier to pharmacy). Proprietary software enables users of Trxade's network to compare prices of branded and generic drugs, and order products at the most favorable prices prevailing at the time of the search. As wholesale price disparities among vendors are most pronounced in generic drugs, the retail pharmacies' searches tend to focus on this segment of the market.

TRXD has developed a pharmacy acquisition cost (PAC) benchmark against which retail pharmacies can compare quoted supplier prices with the average cost charged retail pharmacies. The PAC benchmark is based on data, which includes data obtained in surveys of retail pharmacies and drug wholesalers, statistics on prescription dispensing, and the costs of disposing of old drug inventory.

The company also operates a wholesale business and distributes directly private label pharmaceuticals thru their 100% subsidiary Westminster Pharmaceuticals to these registered members.

The complete 20-page report is available at http://www.researchfrc.com/new/reports/

We do not undertake to advise you as to changes in figures or our views. This is not a solicitation of any order to buy or sell. Fundamental Research Corp. is fully disclosed with its clearing firm, Pershing, LLC, is not a market maker and does not sell to or buy from customers on a principal basis. The above statement is the opinion of Fundamental Research Corp. and is not a guarantee that the target price for the stock will be met or that predicted business results for the company will occur. There may be instances when fundamental, technical and quantitative opinions contained in this report are not in concert. We, our affiliates, any officer, director or stockholder or any member of their families may from time to time purchase or sell any of the above-mentioned or related securities. Analysts and members of the Research Department are prohibited from buying or selling securities issued by the companies that Fundamental Research Corp has a research relationship with, except if ownership of such securities was prior to the start of such relationship, then an Analyst or member of the Research Department may sell such securities after obtaining expressed written permission from Compliance. As of the date of this report no Fundamental Research Corp employees had a position in the stock of the company mentioned in this report.

All research issued by Fundamental Research Corp. is based on public information. Fees were paid by TRXD to FRC. The purpose of the fee is to subsidize the high costs of research and monitoring. FRC takes steps to ensure independence including setting fees in advance and utilizing analysts who must abide by CFA Institute Code of Ethics and Standards of Professional Conduct. Additionally, analysts may not trade in any security under coverage. Our full editorial control of all research, timing of release of the reports, and release of liability for negative reports are protected contractually. To further ensure independence, TRXD has agreed to a minimum coverage term including four reports.

For further information on Fundamental Research Corp ownership data please refer to each individual report.

Contact Information